MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · IEX Real-Time Price · USD
+1.04 (2.33%)
Jul 23, 2024, 4:00 PM EDT - Market closed

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $2.88 billion. The enterprise value is $2.33 billion.

Market Cap 2.88B
Enterprise Value 2.33B

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date Aug 8, 2024
Ex-Dividend Date n/a

Share Statistics

MLTX has 62.87 million shares outstanding. The number of shares has increased by 60.35% in one year.

Shares Outstanding 62.87M
Shares Change (YoY) +60.35%
Shares Change (QoQ) +27.51%
Owned by Insiders (%) 15.27%
Owned by Institutions (%) 97.37%
Float 23.53M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.30
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 62.13, with a Debt / Equity ratio of 0.01.

Current Ratio 62.13
Quick Ratio 61.56
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -9.40% and return on invested capital (ROIC) is -11.17%.

Return on Equity (ROE) -9.40%
Return on Assets (ROA) -8.70%
Return on Capital (ROIC) -11.17%
Revenue Per Employee n/a
Profits Per Employee -$916,713
Employee Count 50
Asset Turnover n/a
Inventory Turnover n/a


In the past 12 months, MLTX has paid $153,632 in taxes.

Income Tax 153,632
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.91% in the last 52 weeks. The beta is 1.25, so MLTX's price volatility has been higher than the market average.

Beta (5Y) 1.25
52-Week Price Change -13.91%
50-Day Moving Average 42.22
200-Day Moving Average 48.85
Relative Strength Index (RSI) 57.36
Average Volume (20 Days) 410,423

Short Selling Information

The latest short interest is 7.83 million, so 12.46% of the outstanding shares have been sold short.

Short Interest 7.83M
Short Previous Month 7.82M
Short % of Shares Out 12.46%
Short % of Float 33.29%
Short Ratio (days to cover) 22.84

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -61.01M
Pretax Income -45.68M
Net Income -45.84M
EBITDA -45.65M
EBIT -45.68M
Earnings Per Share (EPS) -$0.73
Full Income Statement

Balance Sheet

The company has $547.05 million in cash and $3.66 million in debt, giving a net cash position of $543.39 million or $8.64 per share.

Cash & Cash Equivalents 547.05M
Total Debt 3.66M
Net Cash 543.39M
Net Cash Per Share $8.64
Equity (Book Value) 542.55M
Book Value Per Share 8.63
Working Capital 544.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.70 million and capital expenditures -$496,399, giving a free cash flow of -$49.20 million.

Operating Cash Flow -48.70M
Capital Expenditures -496,399
Free Cash Flow -49.20M
FCF Per Share -$0.79
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -60.35%
Shareholder Yield -60.35%
Earnings Yield -1.59%
FCF Yield -1.71%
Dividend Details

Analyst Forecast

The average price target for MLTX is $76.33, which is 66.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target $76.33
Price Target Difference 66.88%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 1